newsfilter
← Latest News
GlobeNewswire·

NeuBase to Present at Oppenheimer's 32nd Annual Healthcare Conference

PITTSBURGH and CAMBRIDGE, Mass., March 07, 2022 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (NASDAQ:NBSE) ("NeuBase" or the "Company"), a biotechnology platform company Drugging the Genome™ to address disease at the base level using a new class o